Sarah Cannon Research Institute (SCRI) physicians authored eight abstracts accepted for presentation at the ASCO 2012 Gastrointestinal Cancers Symposium, which runs from Jan. 24-26 in San Francisco, CA.
“The incorporation of targeted therapies in the treatment of gastrointestinal cancers continues to improve clinical outcomes for patients,” said Howard A. Burris III, M.D., SCRI’s chief medical officer.
